Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia.
Greinix HT, Loidolt H, Rabitsch W, Schulenburg A, Keil F, Mitterbauer M, Laczika K, Lechner K, Dieckmann K, Fischer G, Jäger U, Rosenmayr A, Knöbl P, Schwarzinger I, Höcker P, Mannhalter C, Hinterberger W, Haas OA, Fonatsch C, Kalhs P.
Greinix HT, et al. Among authors: laczika k.
Ann Hematol. 2000 Apr;79(4):206-13. doi: 10.1007/s002770050580.
Ann Hematol. 2000.
PMID: 10834508
Clinical Trial.